Predian in the complex treatment of patients with diabetes mellitus
I. V. Grigorieva
Kazan medical journal ›› 1988, Vol. 69 ›› Issue (4) : 295 -296.
The aim of this work was to study the effectiveness of predian (sulfonamide developed at the Research Institute Servier, France) as a sugar-lowering agent, as well as its effect on the coagulation and antiplatelet systems of diabetic patients.
Eco-Vector
/
| 〈 |
|
〉 |
PDF
